Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Role of ion channels in gastrointestinal cancer.

Anderson KJ, Cormier RT, Scott PM.

World J Gastroenterol. 2019 Oct 14;25(38):5732-5772. doi: 10.3748/wjg.v25.i38.5732. Review.

2.

A novel cancer syndrome caused by KCNQ1-deficiency in the golden Syrian hamster.

Li R, Miao J, Tabaran AF, O'Sullivan MG, Anderson KJ, Scott PM, Wang Z, Cormier RT.

J Carcinog. 2018 Oct 10;17:6. doi: 10.4103/jcar.JCar_5_18. eCollection 2018.

3.

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Than BLN, Linnekamp JF, Starr TK, Largaespada DA, Rod A, Zhang Y, Bruner V, Abrahante J, Schumann A, Luczak T, Walter J, Niemczyk A, O'Sullivan MG, Medema JP, Fijneman RJA, Meijer GA, Van den Broek E, Hodges CA, Scott PM, Vermeulen L, Cormier RT.

Oncogene. 2017 Jun 15;36(24):3504. doi: 10.1038/onc.2017.3. Epub 2017 Feb 13.

PMID:
28192405
4.

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

den Uil SH, Coupé VM, Linnekamp JF, van den Broek E, Goos JA, Delis-van Diemen PM, Belt EJ, van Grieken NC, Scott PM, Vermeulen L, Medema JP, Bril H, Stockmann HB, Cormier RT, Meijer GA, Fijneman RJ.

Br J Cancer. 2016 Dec 6;115(12):1565-1574. doi: 10.1038/bjc.2016.376. Epub 2016 Nov 17.

5.

Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer.

Schewe M, Franken PF, Sacchetti A, Schmitt M, Joosten R, Böttcher R, van Royen ME, Jeammet L, Payré C, Scott PM, Webb NR, Gelb M, Cormier RT, Lambeau G, Fodde R.

Cell Stem Cell. 2016 Jul 7;19(1):38-51. doi: 10.1016/j.stem.2016.05.023. Epub 2016 Jun 9.

6.

Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.

Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y.

Dis Esophagus. 2017 Feb 1;30(2):1-9. doi: 10.1111/dote.12489.

PMID:
27003597
7.

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Than BL, Linnekamp JF, Starr TK, Largaespada DA, Rod A, Zhang Y, Bruner V, Abrahante J, Schumann A, Luczak T, Walter J, Niemczyk A, O'Sullivan MG, Medema JP, Fijneman RJ, Meijer GA, Van den Broek E, Hodges CA, Scott PM, Vermeulen L, Cormier RT.

Oncogene. 2016 Aug 11;35(32):4179-87. doi: 10.1038/onc.2015.483. Epub 2016 Jan 11. Erratum in: Oncogene. 2017 Jun 15;36(24):3504.

8.

Overexpression of phospholipase A2 Group IIA in esophageal squamous cell carcinoma and association with cyclooxygenase-2 expression.

Zhai YC, Dong B, Wei WQ, He Y, Li XQ, Cormier RT, Wang W, Liu F.

Asian Pac J Cancer Prev. 2014;15(21):9417-21.

9.

Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A₂ group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.

Liu F, Wei WQ, Cormier RT, Zhang ST, Qiao YL, Li XQ, Zhu ST, Zhai YC, Peng XX, Yan YX, Wu LJ, He D, He Y.

Asian Pac J Cancer Prev. 2014;15(4):1797-802.

10.

The role of KCNQ1 in mouse and human gastrointestinal cancers.

Than BL, Goos JA, Sarver AL, O'Sullivan MG, Rod A, Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y, Largaespada DA, Scott PM, Cormier RT.

Oncogene. 2014 Jul 17;33(29):3861-8. doi: 10.1038/onc.2013.350. Epub 2013 Aug 26.

11.

A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis.

Bagley BN, Keane TM, Maklakova VI, Marshall JG, Lester RA, Cancel MM, Paulsen AR, Bendzick LE, Been RA, Kogan SC, Cormier RT, Kendziorski C, Adams DJ, Collier LS.

PLoS Genet. 2012;8(11):e1003034. doi: 10.1371/journal.pgen.1003034. Epub 2012 Nov 1.

12.

New methods for finding common insertion sites and co-occurring common insertion sites in transposon- and virus-based genetic screens.

Bergemann TL, Starr TK, Yu H, Steinbach M, Erdmann J, Chen Y, Cormier RT, Largaespada DA, Silverstein KA.

Nucleic Acids Res. 2012 May;40(9):3822-33. doi: 10.1093/nar/gkr1295. Epub 2012 Jan 12.

13.

Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

Fijneman RJ, Anderson RA, Richards E, Liu J, Tijssen M, Meijer GA, Anderson J, Rod A, O'Sullivan MG, Scott PM, Cormier RT.

Cancer Sci. 2012 Mar;103(3):593-9. doi: 10.1111/j.1349-7006.2011.02189.x. Epub 2012 Jan 19.

14.

A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.

Starr TK, Scott PM, Marsh BM, Zhao L, Than BL, O'Sullivan MG, Sarver AL, Dupuy AJ, Largaespada DA, Cormier RT.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5765-70. doi: 10.1073/pnas.1018012108. Epub 2011 Mar 21.

15.

Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways.

Fijneman RJ, Bade LK, Peham JR, van de Wiel MA, van Hinsbergh VW, Meijer GA, O'Sullivan MG, Cormier RT.

Cell Oncol. 2009;31(5):345-56. doi: 10.3233/CLO-2009-0480.

16.

A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.

Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, Collier LS, Powers S, Oberg AL, Asmann YW, Thibodeau SN, Tessarollo L, Copeland NG, Jenkins NA, Cormier RT, Largaespada DA.

Science. 2009 Mar 27;323(5922):1747-50. doi: 10.1126/science.1163040. Epub 2009 Feb 26.

17.

Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis.

Bogan C, Chen J, O'Sullivan MG, Cormier RT.

Int J Cancer. 2009 Mar 15;124(6):1366-71. doi: 10.1002/ijc.24083.

18.

Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice.

Fijneman RJ, Peham JR, van de Wiel MA, Meijer GA, Matise I, Velcich A, Cormier RT.

Cancer Sci. 2008 Nov;99(11):2113-9. doi: 10.1111/j.1349-7006.2008.00924.x.

19.

Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.

Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, Kent S, Bancroft L, Matise I, Cormier RT, Scherer SJ, Edelmann W, Lipkin M, Augenlicht L, Velcich A.

Cancer Res. 2008 Sep 15;68(18):7313-22. doi: 10.1158/0008-5472.CAN-08-0598.

20.

The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.

Fijneman RJ, Cormier RT.

Front Biosci. 2008 May 1;13:4144-74. Review.

PMID:
18508504
21.

Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice.

McAlpine CA, Barak Y, Matise I, Cormier RT.

Int J Cancer. 2006 Nov 15;119(10):2339-46.

23.

The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.

Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, Borenstein N, Lander ES, Dove WF.

Oncogene. 2000 Jun 29;19(28):3182-92.

24.

The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.

Dove WF, Cormier RT, Gould KA, Halberg RB, Merritt AJ, Newton MA, Shoemaker AR.

Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29;353(1370):915-23. Review.

25.

Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.

Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF, Lander ES.

Nat Genet. 1997 Sep;17(1):88-91.

PMID:
9288104

Supplemental Content

Loading ...
Support Center